Researcher
Evelyn Despierre
- Disciplines:Gynaecology and obstetrics, Nursing, Endocrinology and metabolic diseases
Affiliations
- Gynaecological Oncology (Division)
Member
From1 Mar 2015 → 30 Mar 2016 - Department of Development and Regeneration (Department)
Member
From1 Aug 2008 → 31 Jul 2010
Publications
1 - 10 of 10
- Epidermal Growth Factor Receptor (EGFR) Pathway Biomarkers in the Randomized Phase III Trial of Erlotinib Versus Observation in Ovarian Cancer Patients with No Evidence of Disease Progression after First-Line Platinum-Based Chemotherapy (vol 10, pg 583, 2015)(2016)
Authors: Evelyn Despierre, Ignace Vergote, Ryan Anderson, Corneel Coens, Dionyssios Katsaros, Fred R Hirsch, Bram Boeckx, Marileila Varella-Garcia, Annamaria Ferrero, Isabelle Ray-Coquard, et al.
Pages: 429 - 429 - Germline polymorphisms in an enhancer of PSIP1 are associated with progression-free survival in epithelial ovarian cancer(2016)
Authors: Diether Lambrechts, Evelyn Despierre, Els Van Nieuwenhuysen, Sandrina Lambrechts, Ignace Vergote
Pages: 6353 - 68 - Role of genomic alterations as prognostic and predictive factors in epithelial ovarian cancer(2015)
Authors: Evelyn Despierre, Ignace Vergote, Diether Lambrechts
Number of pages: 254 - Epithelial-Mesenchymal Transition (EMT) Gene Variants and Epithelial Ovarian Cancer (EOC) Risk(2015)
Authors: Evelyn Despierre, Diether Lambrechts, Sandrina Lambrechts, Ignace Vergote
Pages: 689 - 97 - Epidermal Growth Factor Receptor (EGFR) Pathway Biomarkers in the Randomized Phase III Trial of Erlotinib Versus Observation in Ovarian Cancer Patients with No Evidence of Disease Progression after First-Line Platinum-Based Chemotherapy(2015)
Authors: Evelyn Despierre, Ignace Vergote, Bram Boeckx, Diether Lambrechts
Pages: 583 - 96 - Common Genetic Variation in Circadian Rhythm Genes and Risk of Epithelial Ovarian Cancer (EOC)(2015)
Authors: Evelyn Despierre, Diether Lambrechts, Sandrina Lambrechts, Ignace Vergote
Pages: 017 - Genetic variability in drug transport, metabolism or DNA repair affecting toxicity of chemotherapy in ovarian cancer(2015)
Authors: Sandrina Lambrechts, Diether Lambrechts, Evelyn Despierre, Els Van Nieuwenhuysen, Dominiek Smeets, Patrick Neven, Frédéric Amant, Karin Leunen, Ignace Vergote
Pages: 2 - The molecular genetic basis of ovarian cancer and its roadmap towards a better treatment(2010)
Authors: Evelyn Despierre, Diether Lambrechts, Patrick Neven, Frédéric Amant, Sandrijne Lambrechts, Ignace Vergote
Pages: 358 - 365 - The molecular genetic basis of ovarian cancer and its roadmap towards a better treatment(2010)
Authors: Evelyn Despierre, Diether Lambrechts, Patrick Neven, Frédéric Amant, Ignace Vergote
Pages: 358 - 365 - Residual tumor after neoadjuvant chemotherapy and interval debulking surgery for advanced endometrial cancer(2009)
Authors: Frédéric Amant, Evelyn Despierre
Pages: 370